Tranche Update on Tasly Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 25, 2020.

From April 23, 2020 to September 30, 2020, the company has repurchased 4,933,845 shares, representing 0.33% for CNY 94.28 million. With this, the company has completed the repurchase of 4,933,845 shares, representing 0.33% for CNY 94.28 million under the buyback announced on April 25, 2020.